Ecolab (ECL) reported $3.94 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 7.3%. EPS of $1.55 for the same period compares to $1.27 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $3.96 billion, representing a surprise of -0.45%. The company delivered an EPS surprise of +0.65%, with the consensus EPS estimate being $1.54.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company’s financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock’s price performance.
Here is how Ecolab performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Sales- Global Institutional & Specialty (Fixed currency): $1.29 billion versus the three-analyst average estimate of $1.26 billion. The reported number represents a year-over-year change of +11.5%.
- Sales- Global Industrial (Fixed currency): $1.87 billion versus the three-analyst average estimate of $1.88 billion. The reported number represents a year-over-year change of +0.3%.
- Sales- Global Healthcare and Life Sciences (Fixed currency): $410.10 million versus the three-analyst average estimate of $413.06 million. The reported number represents a year-over-year change of -4.9%.
- Sales- Other (Fixed currency): $370.10 million compared to the $368.96 million average estimate based on three analysts. The reported number represents a change of +4.4% year over year.
- Sales- Corporate (Fixed currency): $13.80 million compared to the $18.67 million average estimate based on three analysts. The reported number represents a change of -50.2% year over year.
- Sales- Global Institutional & Specialty (Public Currency rates): $1.29 billion compared to the $1.27 billion average estimate based on two analysts.
- Sales- Global Industrial (Public Currency rates): $1.86 billion versus $1.86 billion estimated by two analysts on average.
- Sales- Other (Public Currency rates): $368.20 million versus the two-analyst average estimate of $370.30 million.
- Operating Income- Global Industrial (Fixed currency): $322.20 million compared to the $309.78 million average estimate based on three analysts.
- Operating Income- Global Institutional & Specialty (Fixed currency): $238.70 million versus the three-analyst average estimate of $226.69 million.
- Operating Income- Other (Fixed currency): $68.60 million compared to the $67.73 million average estimate based on three analysts.
- Operating Income- Global Healthcare and Life Sciences (Fixed currency): $48.30 million compared to the $43.11 million average estimate based on three analysts.
View all Key Company Metrics for Ecolab here>>>
Shares of Ecolab have returned +2% over the past month versus the Zacks S&P 500 composite’s +5.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Zacks Names #1 Semiconductor Stock
It’s only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.
With strong earnings growth and an expanding customer base, it’s positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.
See This Stock Now for Free >>
Ecolab Inc. (ECL) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Image and article originally from www.nasdaq.com. Read the original article here.